Press Releases

CHICAGO, Nov. 26, 2019 /PRNewswire/ -- Volpara Solutions, Inc., will showcase its Cancer Screening Platform, powered by artificial intelligence (AI), at the 105th Annual Radiological Soci

ELDON, Mo., Nov. 26, 2019 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Eldon on Monday, November 25th and is conveniently located in downtown Eldon at intersection of South Maple Street at East 3rd S

- Redesigned, mom-favorite pump features USB cord charging and Medela's most efficient breast shields, all with a closed system to support their breast milk feeding goals - On-the-go moms get a consistent, hands-free pumping experience designed for their life MCHENRY, Ill., Nov. 26, 2019 /PRNewswire/ --

SAN DIEGO, Nov. 26, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Amphora®, a Multipurpose Vaginal pH Regulator (MVP-R™), for the prevention of pregnancy.

VANCOUVER, Nov. 26, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced that it has closed its previously announced un

VANCOUVER, Nov. 26, 2019 /PRNewswire/ - Village Farms International, Inc. ("Village Farms") (TSX: VFF; Nasdaq: VFF) today responds to inaccurate and misleading public disclosure by Emerald Health Therapeutics, Inc. ("Emerald") and provides an update in respect of its majority ownership interest in Pure Sunfarms Corp. ("Pure Sunfarms"), as described i

SANTA CLARA, Calif., Nov. 26, 2019 /PRNewswire/ -- Glassbeam today announced new functionalities in its AI-powered Clinsights™ Service Analytics offerings that are targeted at healthcare providers to help improve patient care by minimizing machine downtime and operational costs. In production sites across 100+ facilities across the United States, Clinsigh

ROCKVILLE, Md., Nov. 26, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced it will present at the Evercore ISI 2nd Annual HealthCONx Conference on

SMITHS FALLS, ON, Nov. 26, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company"), is pleased to announce the appointment of Judy Hong as Vice President, Investor Relations, effective December 2, 2019. In her role, Judy will partner with

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, will present at the 31st Annual Piper Jaffray Healthcare Confe